Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay

BACKGROUND: The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the population. Many such assays have been launched by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittel, Maximilian, Findeisen, Peter, Muth, Maria-Christina, Thiaucourt, Margot, Gerhards, Catharina, Neumaier, Michael, Haselmann, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872847/
https://www.ncbi.nlm.nih.gov/pubmed/33578017
http://dx.doi.org/10.1016/j.ijid.2021.02.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872847/
https://www.ncbi.nlm.nih.gov/pubmed/33578017
http://dx.doi.org/10.1016/j.ijid.2021.02.024

Ejemplares similares